Trials / Recruiting
RecruitingNCT05295615
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
Effects of PEMF Treatment on Patients With Mild to Moderate Alzheimer's Disease in a Controlled Pilot Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Herrick Medical LLC · Industry
- Sex
- All
- Age
- 50 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ECHS AD Device | Pulsed electromagnetic therapy device |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2025-12-30
- Completion
- 2026-09-30
- First posted
- 2022-03-25
- Last updated
- 2024-11-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05295615. Inclusion in this directory is not an endorsement.